Transcript
Who should we start on aspirin for the primary prevention of cardiovascular disease? Primary prevention means we’re talking about someone who’s never had a heart attack or stroke. The USPSTF guidelines stated with moderate certainty that there is a small net benefit of daily aspirin in patients aged 40 to 59 with a 10 year CBD risk of 10 percent or more.
In patients over 60, the USPSTF says don’t prescribe, as there’s moderate to high evidence that daily aspirin has no net benefit, or that the harms outweigh the benefit. So, patients aged 40 to 59 with a 10 year CVD risk of 10 percent or more should be selectively prescribed daily aspirin based on physician judgment and patient preferences.
We need to be engaging in shared clinical decision making here. To hear more, check out the Core IM Mind the Gap episode, Aspirin for Primary Prevention.
Full Episode
Tags: aspirin, cardiology, cardiovascular disease, Mind the Gap, primary prevention